A Phase Ib/II Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetic and Pharmacodynamic Characteristics of a Single Subcutaneous Injection of Polyethylene Glycolated Thrombopoietin Peptide (PN20) in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Latest Information Update: 10 Mar 2026
At a glance
- Drugs PN 20 (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Sponsors Chongqing Peg-Bio Biopharm
Most Recent Events
- 10 Mar 2026 New trial record